Background As the use of weight-loss and diabetes medications continues to rise worldwide, more women of reproductive age are becoming pregnant while receiving these treatments, often before realizing they are expecting
Emerging evidence suggests that women receiving hormone therapy demonstrate more favorable weight loss trajectories and body composition outcomes when treated with GLP-1 based therapies than those who are not, particularly in women with preserved metabolic flexibility [16,17]
There was no significant difference between Januvia and placebo in body weight change
Energy can be tricky to define and study, but we can look at data on creatines impact on fatigue in specific circumstances: Older adults were more resilient to physical fatigue after 14 days of high-volume creatine supplementation
Eur J Pharmacol 875:173040 Lee DM, Battson ML, Jarrell DK, Hou S, Ecton KE, Weir TL, Gentile CL (2018) SGLT2 inhibition via dapagliflozin improves generalized vascular dysfunction and alters the gut microbiota in type 2 diabetic mice